Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Convalescent plasma Emergency use authorization Experimental Antiviral May/16/2022 43 10
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Nov/03/2021 41 4
Favipiravir Potential treatment - clinical evidence Used to treat other disease Antiviral Sep/24/2021 27 7
IVIg Potential treatment - clinical evidence Used to treat other disease Other treatment May/23/2021 11 2
Breast milk Potential treatment - pre-clinical evidence Natural product Antiviral Mar/01/2021 4 0
Prednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Feb/09/2021 5 0
Taxifolin Potential treatment - theoretical effect Natural product Antiviral Nov/25/2020 2 0
GD1-69 Potential treatment - pre-clinical evidence Experimental Antiviral Nov/25/2020 1 0
Luminol sodium salt Potential treatment - pre-clinical evidence Experimental Antiviral Nov/20/2020 1 0
Excel (.xslx) CSV (.csv)